KATHRINE LANGLEY: Open Payments
NPI 1407440829 · ANDALUSIA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 18 payments from 10 companies in 2025. Trend: 2023 $213 · 2024 $259 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Lilly USA, LLC | 3 | $54 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Exact Sciences Corporation | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
Products named: Ozempic, REXULTI, AIRSUPRA, MOUNJARO, Auvelity, LAGEVRIO, FARXIGA, JARDIANCE.
Industry payments across AL — which companies pay providers there.
